ImmuCell Corporation Cost of Revenue
ImmuCell Corporation (ICCC) reported Cost of Revenue of $3.63 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2025-08-14
- ImmuCell Corporation cost of goods and services sold for the quarter ending 2025-06-30 was $3.63M, a 14.51% decline year-over-year.
- ImmuCell Corporation cost of goods and services sold for the quarter ending 2025-03-31 was $4.71M, a 5.02% decline year-over-year.
- ImmuCell Corporation cost of goods and services sold for the quarter ending 2024-12-31 was $4.92M, a 28.17% increase year-over-year.
- ImmuCell Corporation cost of goods and services sold for the quarter ending 2024-09-30 was $4.43M, a 7.23% increase year-over-year.
- ImmuCell Corporation cost of goods and services sold for fiscal 2024 was $18.55M, a 36.39% increase from fiscal 2023.
- ImmuCell Corporation cost of goods and services sold for fiscal 2023 was $13.60M.
- ImmuCell Corporation cost of goods and services sold for fiscal 2019 was $6.98M, a 20.56% increase from fiscal 2018.
- ImmuCell Corporation cost of goods and services sold for fiscal 2018 was $5.79M, a 11.18% increase from fiscal 2017.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2025-06-30 | $3.63M 10-Q · filed 2025-08-14 | $8.34M 10-Q · filed 2025-08-14 | $13.26M derived: sum of 3 quarters · filed 2025-08-14 | $17.69M derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $4.71M 10-Q · filed 2025-05-14 | $9.63M derived: sum of 2 quarters · filed 2025-05-14 | $14.06M derived: sum of 3 quarters · filed 2025-05-14 | $18.30M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $9.35M derived: sum of 2 quarters · filed 2025-03-28 | $13.59M derived: sum of 3 quarters · filed 2025-08-14 | $18.55M 10-K · filed 2025-03-28 |
| 2024-09-30 | $4.43M 10-Q · filed 2024-11-13 | $8.67M derived: sum of 2 quarters · filed 2025-08-14 | $13.63M 10-Q · filed 2024-11-13 | $17.47M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $4.24M 10-Q · filed 2025-08-14 | $9.20M 10-Q · filed 2025-08-14 | $13.04M derived: sum of 3 quarters · filed 2025-08-14 | $17.17M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.96M 10-Q · filed 2025-05-14 | $8.80M derived: sum of 2 quarters · filed 2025-05-14 | $12.93M derived: sum of 3 quarters · filed 2025-05-14 | $15.42M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $7.97M derived: sum of 2 quarters · filed 2025-03-28 | $10.46M derived: sum of 3 quarters · filed 2025-03-28 | $13.60M 10-K · filed 2025-03-28 |
| 2023-09-30 | $4.13M 10-Q · filed 2024-11-13 | $6.62M derived: sum of 2 quarters · filed 2024-11-13 | $9.76M 10-Q · filed 2024-11-13 | $12.68M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $2.49M 10-Q · filed 2024-08-13 | $5.63M 10-Q · filed 2024-08-13 | $8.55M derived: sum of 3 quarters · filed 2024-11-13 | $11.50M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-03-31 | $3.15M 10-Q · filed 2024-05-14 | $6.06M derived: sum of 2 quarters · filed 2024-11-13 | $9.01M derived: sum of 3 quarters · filed 2024-11-13 | $11.17M derived: sum of 4 quarters · filed 2024-11-13 |
| 2022-12-31 | $2.92M derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-13 | $5.87M derived: sum of 2 quarters · filed 2024-11-13 | $8.02M derived: sum of 3 quarters · filed 2024-11-13 | $10.92M 10-Q · filed 2024-11-13 |
| 2022-09-30 | $2.95M 10-Q · filed 2023-11-13 | $5.10M derived: sum of 2 quarters · filed 2023-11-13 | $8.00M 10-Q · filed 2023-11-13 | $10.88M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $2.15M 10-Q · filed 2023-08-10 | $5.05M 10-Q · filed 2023-08-10 | $7.93M derived: sum of 3 quarters · filed 2023-11-13 | $10.67M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-03-31 | $2.90M 10-Q · filed 2023-05-11 | $5.78M derived: sum of 2 quarters · filed 2023-11-13 | $8.51M derived: sum of 3 quarters · filed 2023-11-13 | $10.98M derived: sum of 4 quarters · filed 2023-11-13 |
| 2021-12-31 | $2.88M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-13 | $5.61M derived: sum of 2 quarters · filed 2023-11-13 | $8.08M derived: sum of 3 quarters · filed 2023-11-13 | $10.59M 10-Q · filed 2023-11-13 |
| 2021-09-30 | $2.73M 10-Q · filed 2022-11-21 | $5.20M derived: sum of 2 quarters · filed 2022-11-21 | $7.70M 10-Q · filed 2022-11-21 | $9.83M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $2.47M 10-Q/A · filed 2022-11-21 | $4.97M 10-Q/A · filed 2022-11-21 | $7.09M derived: sum of 3 quarters · filed 2022-11-21 | $9.09M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $2.50M 10-Q/A · filed 2022-11-21 | $4.63M derived: sum of 2 quarters · filed 2022-11-21 | $6.63M derived: sum of 3 quarters · filed 2022-11-21 | $8.31M derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $2.12M derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-21 | $4.12M derived: sum of 2 quarters · filed 2022-11-21 | $5.81M derived: sum of 3 quarters · filed 2022-11-21 | $8.48M 10-Q/A · filed 2022-11-21 |
| 2020-09-30 | $2.00M 10-Q · filed 2021-11-15 | $3.68M derived: sum of 2 quarters · filed 2021-11-15 | $6.36M 10-Q · filed 2021-11-15 | $8.15M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.68M 10-Q · filed 2021-08-12 | $4.36M 10-Q · filed 2021-08-12 | $6.15M derived: sum of 3 quarters · filed 2021-08-12 | $7.67M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $2.67M 10-Q · filed 2021-05-13 | $4.47M derived: sum of 2 quarters · filed 2021-05-13 | $5.99M derived: sum of 3 quarters · filed 2021-05-13 | $7.45M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $3.31M derived: sum of 2 quarters · filed 2021-03-30 | $4.77M derived: sum of 3 quarters · filed 2021-03-30 | $6.98M 10-K · filed 2021-03-30 |
| 2019-09-30 | $1.52M 10-Q · filed 2020-11-12 | $2.98M derived: sum of 2 quarters · filed 2020-11-12 | $5.19M 10-Q · filed 2020-11-12 | $6.73M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.46M 10-Q · filed 2020-08-12 | $3.67M 10-Q · filed 2020-08-12 | $5.21M derived: sum of 3 quarters · filed 2020-08-12 | $6.41M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $2.21M 10-Q · filed 2020-05-13 | $3.75M derived: sum of 2 quarters · filed 2020-05-13 | $4.95M derived: sum of 3 quarters · filed 2020-05-13 | $6.48M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.74M derived: sum of 2 quarters · filed 2020-03-27 | $4.27M derived: sum of 3 quarters · filed 2020-03-27 | $5.79M 10-K · filed 2020-03-27 |
| 2018-09-30 | $1.20M 10-Q · filed 2019-11-12 | $2.73M derived: sum of 2 quarters · filed 2019-11-12 | $4.25M 10-Q · filed 2019-11-12 | $6.17M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.53M 10-Q · filed 2019-08-12 | $3.05M 10-Q · filed 2019-08-12 | $4.97M derived: sum of 3 quarters · filed 2019-08-12 | $6.04M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $1.52M 10-Q · filed 2019-05-13 | $3.44M derived: sum of 2 quarters · filed 2019-05-13 | $4.51M derived: sum of 3 quarters · filed 2019-05-13 | $5.34M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $2.99M derived: sum of 2 quarters · filed 2019-03-22 | $3.82M derived: sum of 3 quarters · filed 2019-03-22 | $5.21M 10-K · filed 2019-03-22 |
| 2017-09-30 | $1.07M 10-Q · filed 2018-11-13 | $1.90M derived: sum of 2 quarters · filed 2018-11-13 | $3.29M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $828.25K 10-Q · filed 2018-08-13 | $2.22M 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |